Language:

Lipid-Lowering Therapy and Outcomes in Heart Failure

Journal of cardiovascular pharmacology and therapeutics, 2007-03, Vol.12 (1), p.27-35

ISSN: 1074-2484 ;EISSN: 1940-4034 ;DOI: 10.1177/1074248407299839 ;PMID: 17495255

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Lipid-Lowering Therapy and Outcomes in Heart Failure
Author: Ray, Joel G. ; Norris, Colleen M. ; Udell, Jacob A. ; Tsuyuki, Ross T. ; McAlister, Finlay A. ; Knudtson, Merril L. ; Ghali, William A.
Subjects: Aged ; Cohort Studies ; Coronary Angiography - methods ; Female ; Follow-Up Studies ; Heart Failure - drug therapy ; Heart Failure - physiopathology ; Heart Function Tests ; Heart Rate - drug effects ; Humans ; Hypolipidemic Agents - therapeutic use ; Male ; Prospective Studies ; Review Literature as Topic ; Severity of Illness Index ; Survival Analysis ; Time Factors ; Treatment Outcome ; Ventricular Function, Left - drug effects
Is Part Of: Journal of cardiovascular pharmacology and therapeutics, 2007-03, Vol.12 (1), p.27-35
Description: Lipid-lowering therapy, particularly with statins, reduces the risk of cardiovascular mortality; however, there is uncertainty about their efficacy in patients with heart failure, including those without coronary artery stenosis. A clinical database was studied to determine whether lipid-lowering therapy is associated with improved survival in persons with heart failure—with or without concomitant coronary artery stenosis. During an 8-year period, 6060 people with a history of heart failure underwent coronary angiography. At the time of angiography, 1216 received a lipid-lowering agent. During a median follow-up of 4.7 years, 7.1 deaths per 100 person-years occurred among users of lipid-lowering therapy, compared with 7.8 per 100 person-years among nonusers (adjusted hazard ratio 0.87, 95% confidence interval 0.77-0.97). Use of lipid-lowering therapy was associated with a reduced risk of death in patients with heart failure. Current evidence supports statin use in individuals with recognized heart failure and concomitant coronary heart disease, dyslipidemia, or diabetes mellitus. More data are needed before statins can be recommended in those with isolated heart failure.
Publisher: Los Angeles, CA: SAGE Publications
Language: English
Identifier: ISSN: 1074-2484
EISSN: 1940-4034
DOI: 10.1177/1074248407299839
PMID: 17495255
Source: Journals@Ovid Open Access Journal Collection Rolling
MEDLINE
Alma/SFX Local Collection

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Lipid-Lowering Therapy and Outcomes in Heart Failure

ISSN: 1074-2484 ;EISSN: 1940-4034 ;DOI: 10.1177/1074248407299839 ;PMID: 17495255

Searching Remote Databases, Please Wait